Eli Lilly



Ebitda Zmiana Data
AbbVie USD 6.92B 258M 2024-12
Abbott USD 2.66B 265M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Baxter International USD 576M 116M 2024-12
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Drreddys Laboratories INR 23.31B 1.4B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Indivior 9M 92M 2024-09
J&J USD 6.12B 1.51B 2024-12
Medtronic USD 2.44B 134M 2025-01
Merck USD 7.12B 1.06B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Novo Nordisk 35.97B 1.19B 2024-09
Perrigo USD 245.1M 49.4M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Prestige Brands USD 98.83M 6.56M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.25B 2.22B 2024-09
Sanofi EUR 4.49B 2.47B 2024-09
United Therapeutics USD 383.4M 43.9M 2024-12
Zoetis USD 894M 145M 2024-12



Eli Lilly - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.